BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 38717194)

  • 1. Beyond the Maze: Recent Advancements in Molecular and Cellular Tethered Drug Delivery Systems.
    Singh D
    Assay Drug Dev Technol; 2024; 22(4):203-215. PubMed ID: 38717194
    [No Abstract]   [Full Text] [Related]  

  • 2. Genetically engineered bacteria: a new frontier in targeted drug delivery.
    Fooladi S; Rabiee N; Iravani S
    J Mater Chem B; 2023 Nov; 11(42):10072-10087. PubMed ID: 37873584
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unveiling innovative therapeutic strategies and future trajectories on stimuli-responsive drug delivery systems for targeted treatment of breast carcinoma.
    Naser IH; Zaid M; Ali E; Jabar HI; Mustafa AN; Alubiady MHS; Ramadan MF; Muzammil K; Khalaf RM; Jalal SS; Alawadi AH; Alsalamy A
    Naunyn Schmiedebergs Arch Pharmacol; 2024 Jun; 397(6):3747-3770. PubMed ID: 38095649
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A neoteric annotation on the advances in combination therapy for Parkinson's disease: nanocarrier-based combination approach and future anticipation. Part II: nanocarrier design and development in focus.
    Unnithan D; Sartaj A; Iqubal MK; Ali J; Baboota S
    Expert Opin Drug Deliv; 2024 Mar; 21(3):437-456. PubMed ID: 38507231
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biologics, theranostics, and personalized medicine in drug delivery systems.
    Puccetti M; Pariano M; Schoubben A; Giovagnoli S; Ricci M
    Pharmacol Res; 2024 Mar; 201():107086. PubMed ID: 38295917
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Applications of Nanotechnology-mediated Herbal Nanosystems for Ophthalmic Drug.
    Shree D; Patra CN; Sahoo BM
    Pharm Nanotechnol; 2024; 12(3):229-250. PubMed ID: 37587812
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advances in Nanotechnology for Enhancing the Solubility and Bioavailability of Poorly Soluble Drugs.
    Liu Y; Liang Y; Yuhong J; Xin P; Han JL; Du Y; Yu X; Zhu R; Zhang M; Chen W; Ma Y
    Drug Des Devel Ther; 2024; 18():1469-1495. PubMed ID: 38707615
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Advancing Role of Nanocomposites in Cancer Diagnosis and Treatment.
    Andoh V; Ocansey DKW; Naveed H; Wang N; Chen L; Chen K; Mao F
    Int J Nanomedicine; 2024; 19():6099-6126. PubMed ID: 38911500
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent Advances in Pharmaceutical Design: Unleashing the Potential of Novel Therapeutics.
    Prajapati RN; Bhushan B; Singh K; Chopra H; Kumar S; Agrawal M; Pathak D; Chanchal DK; Laxmikant
    Curr Pharm Biotechnol; 2024 Jan; ():. PubMed ID: 38288793
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advancements in Nanosystems for Ocular Drug Delivery: A Focus on Pediatric Retinoblastoma.
    Wu KY; Wang XC; Anderson M; Tran SD
    Molecules; 2024 May; 29(10):. PubMed ID: 38792122
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exploiting nuclear-mitochondrial cross-talk in theranostics: Enhancing drug delivery and diagnostic precision.
    Singh D
    Mitochondrion; 2024 Mar; 75():101839. PubMed ID: 38158150
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug Delivery System Approaches for Rheumatoid Arthritis Treatment: A Review.
    Garhwal A; Kendya P; Soni S; Kori S; Soni V; Kashaw SK
    Mini Rev Med Chem; 2024; 24(7):704-720. PubMed ID: 37711105
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nanocarriers: Exploring the Potential of Oligonucleotide Delivery.
    Alsaidan OA
    Curr Drug Deliv; 2024 Jun; ():. PubMed ID: 38918987
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integrating natural compounds and nanoparticle-based drug delivery systems: A novel strategy for enhanced efficacy and selectivity in cancer therapy.
    Manzari-Tavakoli A; Babajani A; Tavakoli MM; Safaeinejad F; Jafari A
    Cancer Med; 2024 Mar; 13(5):e7010. PubMed ID: 38491817
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multifunctional cell membranes-based nano-carriers for targeted therapies: a review of recent trends and future perspective.
    Li M; Guo Q; Zhong C; Zhang Z
    Drug Deliv; 2023 Dec; 30(1):2288797. PubMed ID: 38069500
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advancements in nanomedicine: Precision delivery strategies for male pelvic malignancies - Spotlight on prostate and colorectal cancer.
    Yang G; Cao Y; Yang X; Cui T; Tan NZV; Lim YK; Fu Y; Cao X; Bhandari A; Enikeev M; Efetov S; Balaban V; He M
    Exp Mol Pathol; 2024 Jun; 137():104904. PubMed ID: 38788248
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nanoparticle Delivery Systems for DNA/RNA and their Potential Applications in Nanomedicine.
    Shen H; Huang X; Min J; Le S; Wang Q; Wang X; Dogan AA; Liu X; Zhang P; Draz MS; Xiao J
    Curr Top Med Chem; 2019; 19(27):2507-2523. PubMed ID: 31775591
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Advancement and Obstacles in Improving the Stability of Nanocarriers for Precision Drug Delivery in the Field of Nanomedicine.
    Mahajan K; Bhattacharya S
    Curr Top Med Chem; 2024; 24(8):686-721. PubMed ID: 38409730
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bio-vehicles of cytotoxic drugs for delivery to tumor specific targets for cancer precision therapy.
    Al-Mansoori L; Elsinga P; Goda SK
    Biomed Pharmacother; 2021 Dec; 144():112260. PubMed ID: 34607105
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Patent Review on Nanotechnology-Based Nose-to-Brain Drug Delivery.
    Singh R; Brumlik C; Vaidya M; Choudhury A
    Recent Pat Nanotechnol; 2020; 14(3):174-192. PubMed ID: 32384043
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.